Archive | Cancer in the News

Ipilimumab Approved by FDA for Pediatric Melanoma

Ipilimumab (Yervoy) has been approved by the FDA for the treatment of patients aged greater than or equal to 12 years with unresectable or metastatic melanoma, according to Bristol-Myers Squibb (BMS), the manufacturer of the CTLA-4 inhibitor.

Read the full story

Posted in Melanoma In The News, FDA

Melanoma Journal Articles for June 2017

“Finding NEMO” in NRAS-mutant melanoma: a step towards a sequential strategy?

Read the full story

Posted in Journal Articles

FDA grants orphan drug designation to pIL-12 for unresectable melanoma

The FDA granted orphan drug designation to tavokinogene telsaplasmid for the treatment of unresectable metastatic melanoma, according to the agent’s manufacturer.

Read the full story

Posted in Melanoma In The News, FDA

Melanoma Journal Articles for May 2017

Whole-genome landscapes of major melanoma subtypes

Read the full story

Posted in Journal Articles

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories